Search Results - "Gaman, Mihnea A"

Dominance of mutations in epigenetic regulators and a diversity of signaling alterations in blast-phase BCR::ABL1-negative myeloproliferative neoplasms by Gurban, Petruta, Mambet, Cristina, Botezatu, Anca, Necula, Laura G, Matei, Lilia, Neagu, Ana Iulia, Pitica, Ioana, Ataman, Marius, Tatic, Aurelia, Bardas, Alexandru, Gaman, Mihnea A, Dobrea, Camelia, Dragomir, Mihaela, Ghimici, Cecilia, Angelescu, Silvana, Barbu, Doina, Stanca, Oana, Danila, Marina, Berbec, Nicoleta, Colita, Andrei, Vladareanu, Ana Maria, Nedeianu, Saviana, Chivu-Economescu, Mihaela, Bleotu, Coralia, Coriu, Daniel, Sepulchre, Elise, Anton, Gabriela, Diaconu, Carmen C, Constantinescu, Stefan N

Get full text

Cardio metabolic risk factors for atrial fibrillation in type 2 diabetes mellitus: Focus on hypertension, metabolic syndrome and obesity by Gaman, Mihnea-Alexandru, Dobrica, Elena-Codruta, Pascu, Emilia, Cozma, Matei-Alexandru, Epingeac, Mirela-Elena, Gaman, Amelia, Stoian, Anca, Bratu, Ovidiu, Diaconu, Camelia

“…Objective. Atrial fibrillation (AF) in type 2 diabetes mellitus (T2DM) has been little explored so far. However, there are several cardio metabolic risk…”
Get full text

SGLT2 inhibition in patients with type 2 diabetes and cardiovascular diseases which are the benefits by Diaconu, Camelia, Salmen, Teodor, Gaman, Mihnea A, Bratu, Ovidiu G, Mischianu, Dan, Marcu, Radu D, Suceveanu, Andra I, Costache, Raluca S, Pantea Stoian, Anca

“…Two major trials, EMPA-REG OUTCOME trial (with Empagliflozin) and CANVAS trial (with Canagliflozin) have demonstrated the beneficial effects of SGLT2…”
Get full text

Effect of Hydroxychloroquine, Favipiravir, Lopinavir/Ritonavir, Remdesivir, Umifenovir, and Interferon beta-1a in Covid-19 patients: A systematic review of Randomized Clinical Trials by Pezeshki, Mehran, Gouvarchinghaleh, Hadi E., Ghahremanian, Amirhossein, Gaman, Mihnea, Farzanehpour, Mahdieh

“…"Background: Coronavirus disease 2019 (COVID-19) was recognized by the World Health Organization (WHO) as a global pandemic on March 11, 2020. Since then,…”
Get full text

The Impact of Low Advanced Glycation End Products Diet on Metabolic Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials by Sohouli, Mohammad Hasan, Fatahi, Somaye, Sharifi-Zahabi, Elham, Santos, Heitor O, Tripathi, Nishant, Lari, Abolfazl, Pourrajab, Behnaz, Kord-Varkaneh, Hamed, Găman, Mihnea-Alexandru, Shidfar, Farzad

“…Several randomized clinical trials have investigated the effect of dietary advanced glycation end products (AGEs) on metabolic syndrome risk factors in adults…”
Get full text